Features

Inflammatory Bowel Diseases (IBD)

Dual Biologic Therapy in Crohn’s Disease: A New Treatment Paradigm?

By

Andy Kistler, MD, PharmD

There is significant interest in optimizing medical treatments of Crohn’s disease (CD) in hopes of preventing complications and the need for surgery.

General Gastroenterology

COVID-19: Atypical GI Presentations

By

Andy Kistler, MD, PharmD

There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain.

General Gastroenterology

The United States Test Against COVID-19

By

Utsav Aiya, MD

Mitigating the spread of a virus as infectious as SARS-CoV-2 requires having ample and accurate diagnostic tests available. However, in the United States, community transmission began to occur before adequate testing measures could be implemented.

General Gastroenterology

The Most Cases of COVID-19 Are in the United States: 5 Updates on the Pandemic

By

Natasha Priya Dyal, MD

The effects of the COVID-19 pandemic have caused more significant change than previously expected as the United States now has the most cases worldwide.

Inflammatory Bowel Diseases (IBD)

Ulcerative Colitis and Fecal Transplantation: Where are We Now?

By

Andy Kistler, MD, PharmD

It is thought that dysregulation of the gut microbiome could cause increased production of pro-inflammatory toxins that can predispose patients to the development of UC.

Microbiome

The Relationship Between Gut Microbiota and Neurodegenerative Disorders

By

Tori Rodriguez, MA, LPC, AHC

The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.

General Gastroenterology

Optimizing Dietary Habits to Combat COVID-19

By

Dibash Kumar Das, PhD

Many have emphasized the need to incorporate alternative strategies to reduce the long-term impacts of the COVID-19 pandemic.

General Gastroenterology

AGA Guidelines Regarding GI Procedures During the COVID-19 Pandemic

By

Andy Kistler, MD, PharmD

An area that has been specifically challenging within gastroenterology is the management of how and when to perform GI procedures, especially when many patients with COVID-19 have gastrointestinal (GI) symptoms.

Practice Management

Do Physician Rating and Ranking Sites Work?

By

Vivek Singh

In healthcare, the choices patients make can have direct consequences on their care. Nowhere is this more evident than in their choice of physician.

Liver

Neurocognitive Impairment in Chronic HCV Infection

By

Tori Rodriquez, MA, LPC, AHC

In the United States, approximately 3.5 million people are infected with the hepatitis C virus, which contributes to psychological and cognitive disorders for about half of all patients.

Esophagus

Barrett Esophagus Recurrence After Complete Eradication of Intestinal Metaplasia

By

Andy Kistler, MD, PharmD

Surveillance recommendations are based on the initial grade of dysplasia.

Liver

A Case of Hepatomegaly, Abdominal Pain, and Ascites

By

Mary-Kate Hunnicutt, PA-C

Alicia Elam, PharmD

Michael Felz, MD

Causes of Budd-Chiari syndrome include myeloproliferative syndromes, malignancy, infection, and Behҫet syndrome.

Inflammatory Bowel Diseases (IBD)

Etrasimod in UC: Promising Phase 2 Results

By

Andy Kistler, MD, PharmD

Researchers evaluated the efficacy and safety of etrasimod, an oral, selective sphingosine 1-phosphate receptor modulator in development for immune-mediated inflammatory disorders, in patients with moderate to severe ulcerative colitis.

Colorectal neoplasia

AF and Anticoagulation: Consider CRC in Patients With Lower GI Bleeding

By

Andy Kistler, MD, PharmD

The absolute 1-year risk of colorectal cancer in patients with atrial fibrillation treated with oral anticoagulants is not trivial.

Colorectal neoplasia

ASGE Recommendations for Endoscopy in FAP Syndromes

By

Gastroenterology Advisor Contributing Writer

The American Society for Gastrointestinal Endoscopy convened a panel to create recommendations for the use of endoscopy in patients with familial adenomatous polyposis syndrome.

General Gastroenterology

COVID-19: What Gastroenterologists Need to Know

By

Andy Kistler, MD, PharmD

Although patients with COVID-19 are known to present with constitutional and respiratory symptoms such as fever, cough, sore throat, and shortness of breath, there is growing evidence that these patients can also experience significant gastrointestinal symptoms such as nausea, vomiting, and diarrhea.

General Gastroenterology

An Overview of Gastrointestinal Dysfunction in Systemic Sclerosis

By

Tori Rodriguez, MA, LPC, AHC

Eric Dein, MD, discusses the pathophysiology, presentation, diagnostic approach, and symptom management of gastrointestinal dysmotility in systemic sclerosis.

Liver

Perioperative Management of Patients With Cirrhosis

By

Tori Rodriguez, MA, LPC, AHC

The challenges associated with managing cirrhosis in patients undergoing non-hepatic surgery specifically are discussed.

Inflammatory Bowel Diseases (IBD)

The Efficacy of Tofacitinib and Other JAK Inhibitors in UC

By

Gastroenterology Advisor Contributing Writer

Tofacitinib is the first JAK inhibitor approved by the FDA for the treatment of UC in patients whose disease worsened or did not improve with conventional therapy.

Colorectal neoplasia

Weighing Benefits and Risks: Colorectal Cancer Screening in Older Adults

By

Gastroenterology Advisor Contributing Writer

Current guidance from the US Preventive Services Task Force recommends against screening patients older than 85 years for colorectal cancer.